- Home
- ZNTL vs NRIM Comparison
ZNTL vs NRIM Comparison
Compare ZNTL & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZNTL | NRIM |
|---|---|---|
| Founded | 2014 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 551.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | NRIM |
|---|---|---|
| Price | $1.36 | $27.57 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 758.1K | 166.9K |
| Earning Date | 11-10-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 2.32% |
| EPS Growth | N/A | ★ 91.08 |
| EPS | N/A | ★ 2.80 |
| Revenue | $26,865,000.00 | ★ $201,544,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.55 |
| P/E Ratio | ★ N/A | $9.83 |
| Revenue Growth | N/A | ★ 42.34 |
| 52 Week Low | $1.01 | $16.18 |
| 52 Week High | $3.33 | $28.21 |
Technical Indicators
Market Signals| Indicator | ZNTL | NRIM |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 60.84 |
| Support Level | $1.33 | $26.80 |
| Resistance Level | $1.46 | $27.80 |
| Average True Range (ATR) | 0.07 | 0.81 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 33.33 | 84.41 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.